Various cell types related to regenerative medicine
Various cell types related to regenerative medicine
Logo

Pluripotent stem cell (PSC) differentiation into cardiomyocytes

Directed cardiomyocyte differentiation of human pluripotent stem cells (hPSCs) is a major tool for the development of disease models, drug screening platforms, and regenerative medicine. Our reliable StemMACS™ Reagents, gentle cell isolation kit, and lot-to-lot consistent REAfinity® Recombinant Antibodies provide standardized solutions for accurate and reproducible results, while our CliniMACS Prodigy® enables you to automate the whole expansion and differentiation process.

Our workflow offers consistent, time-saving, and reliable hPSC differentiation solutions, making cardiomyocytes ready for any downstream application.

Content overview

Content

  • Workflow overview
  • 1. Efficient cardiomyocyte differentiation protocol
  • 2. Reliable culture of PSC-derived cardiomyocytes
  • 3. Effortless cardiomyocyte isolation
  • 4. Precise cardiomyocyte characterization
  • Automated and scalable differentiation of PSCs into cardiomyocytes
  • Step-by-step protocols

Workflow overview

We support you at every step of your research with a seamlessly integrated approach, connecting reliable PSC culture and maintenance to fast and efficient cardiomyocyte differentiation, isolation, and characterization.

Infographic showing the PSC differentiation into cardiomyocytes workflow
PSC differentiation into cardiomyocytes workflow
Brochure

Pluripotent stem cell research

Pioneering solutions and integrated workflows for induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs).

1. Efficient cardiomyocyte differentiation protocol

Reliable PSC maintenance ensures efficient differentiation

Efficient differentiation starts with high-quality PSCs. To ensure your cells are highly pluripotent and can readily differentiate into any desired lineage, it is crucial to maintain them in balanced and carefully optimized media formulations and verify their pluripotency potential using reliable reagents and validated antibodies.

Our media – StemMACS PSC-Brew XF, human, and StemMACS iPS-Brew XF, human – are specifically designed to provide your cells with nutrients of the highest quality, sustaining robust growth while maintaining a pluripotent phenotype and a high differentiation potential. Compatible with recombinant, chemically defined, xeno-free MACSmatrix Laminin 511, these media ensure consistent and reproducible results. With StemMACS PSC-Brew XF, human, you can enjoy a flexible feeding schedule thanks to its optimized nutrient supply, stable pH, and stable FGF-2 (IS).

PSCs can be efficiently assessed using the PSC Analysis Cocktail Kit, anti-human ensuring reproducibility and minimizing effort

Infographic showing the differentiation to cardiomyocytes in just eight days using the StemMACS CardioDiff Kit XF, human
Fast and easy iPSC cardiomyocyte differentiation protocol of hPSCs.

Efficient cardiomyocyte differentiation induction

Supercharge your cardiomyocyte research with StemMACS CardioDiff Kit XF, human engineered for an effortless and rapid differentiation process in just eight days.
Bar chart showing that the StemMACS CardioDiff Kit XF, human yields high differentiation efficiencies when differentiating PSCs to cardiomyocytes
StemMACS CardioDiff Kit XF, human yields high differentiation efficiencies.

Achieve consistent, high-efficiency differentiation with our xeno-free, ready-to-use system, eliminating the need for extra patterning factors and ensuring reliable outcomes every time. Enhance your workflows further with MACSmatrix Laminin 511, a recombinant, chemically defined, xeno-free matrix that supports robust and reproducible differentiation.

Unmatched flexibility for tailored cardiomyocyte differentiation

StemMACS CardioDiff Kit XF, human, offers unmatched flexibility, allowing you to choose your preferred culture method and effortlessly generate specific cardiomyocyte subtypes to meet your research goals.

Obtain PSC-derived cardiomyocytes as adherent culture or cardiospheres

StemMACS CardioDiff Kit XF, human can be used with adherent PSC cultures to obtain a monolayer of highly functional PSC-derived cardiomyocytes. Additionally, it can be used to differentiate three-dimensional PSC aggregates into beating cardiospheres.

Video

Beating cardiomyocytes, derived from an adherent PSC culture that was differentiated with StemMACS CardioDiff Kit XF, human.

Video

Three-dimensional PSC-derived cardiospheres differentiated with StemMACS CardioDiff Kit XF, human.

Scientific data showing that StemMACS CardioDiff Kit XF, human leads to the generation of ventricular-like cardiomyocytes and, if supplemented with retinoic acid, to atrial-like cardiomyocytes
Differentiation of ventricular- and atrial-like cardiomyocytes with StemMACS CardioDiff Kit XF, human.

Obtain ventricular- or atrial-like cardiomyocytes

StemMACS CardioDiff Kit XF, human leads to the generation of ventricular-like cardiomyocytes and, if supplemented with retinoic acid, to atrial-like cardiomyocytes.

2. Reliable culture of PSC-derived cardiomyocytes

Bar charts showing that StemMACS Cryo-Brew enables cryopreservation of hPSC-derived cardiomyocytes with high recovery and viability after thawing
StemMACS Cryo-Brew enables cryopreservation of hPSC-derived cardiomyocytes with high recovery and viability after thawing.

Ensure consistent and reliable cultivation of your hPSC-derived cardiomyocytes for over 30 days with our xeno-free cell culture medium, StemMACS Cardiac Cultivation Medium XF, human. For long-term storage, StemMACS Cryo-Brew offers an animal component–free, chemically defined cryopreservation solution that guarantees high thawing efficiency, excellent cell viability, and rapid culture re-initiation.

Scientific data showing that cardiomyocytes, generated with StemMACS CardioDiff Kit XF, human, show the expression of typical cardiomyocyte markers
hPSC-derived cardiomyocyte characterization.

After thawing, culture your cardiomyocytes in StemMACS Cardiac Cultivation Medium XF, human, to ensure rapid recovery, sustained expression of characteristic markers, and maintenance of typical morphology throughout.

3. Effortless cardiomyocyte isolation

For reliable experimental outcomes, working with highly homogeneous cultures of accurately differentiated PSC-derived cardiomyocytes is essential.

Dissociate your PSC-derived cardiomyocyte culture gently

Optimize dissociation efficiency with the gentle yet effective combination of Multi Tissue Dissociation Kit 3 and the gentleMACS® Octo Dissociator with Heaters. The tissue is enzymatically digested using the kit components, while the instrument handles the mechanical dissociation steps with precision.

Infographic showing cardiomyocyte isolation strategies using the PSC-derived Cardiomyocyte Isolation Kit, human
Cardiomyocyte isolation strategies using the PSC-derived Cardiomyocyte Isolation Kit, human.

Obtain highly pure and viable cardiomyocytes

The PSC-Derived Cardiomyocyte Isolation Kit, human, stands out from metabolic selection methods by preserving the phenotype while delivering high yields of viable, functional cardiomyocytes.

Streamline your workflow with an efficient, fast, and easy two-step magnetic cell separation process, ensuring the depletion of non-cardiomyocytes and the enrichment of highly pure PSC-derived cardiomyocytes (up to 97% purity). Importantly, cell isolation is independent of the differentiation protocol, hPSC line used, time point, or efficacy of differentiation.

4. Precise cardiomyocyte characterization

Scientific data showing the immunophenotyping of cardiomyocytes derived from hPSCs using flow cytometry
Immunophenotyping of cardiomyocytes derived from hPSCs using flow cytometry.

PSC-derived cardiomyocyte cultures include various subtypes, such as atrial-like, ventricular-like, and pacemaker-like cells. Traditionally, these subpopulations have been characterized through lengthy and complex electrophysiological analysis.

Simplify and accelerate your analysis by flow cytometry using the Miltenyi Biotec–tested antibody panel (MBTP) 6, which saves time while providing both qualitative and quantitative insights. Leveraging novel REAfinity Antibodies, this flow cytometry panel precisely targets cardiomyocyte populations and accurately detects ventricular and atrial subpopulations.

Automated and scalable differentiation of PSCs into cardiomyocytes

Unlock efficient scalability with the CliniMACS Prodigy Adherent Cell Culture process and ready-to-use, xeno-free StemMACS CardioDiff Kit XF, human, enabling fast and robust PSC expansion and differentiation into cardiomyocytes within a closed, automated system.

Step-by-step protocols for PSC differentiation into cardiomyocytes

Get acquainted with our protocols for your workflows in research with pluripotent stem cells.

You have previously chosen International as your location.
What do you want to do?